Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration.

Current drug delivery

Volumn 1, Issue 1, 2004, Pages 9-15

  Babiuk, Shawn ^a   Baca Estrada, Maria E ^a   Middleton, Dorothy M ^a   Hecker, Rolf ^a   Babiuk, Lorne A ^a   Foldvari, Marianna ^a  

^a PharmaDerm Laboratories Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DRUG CARRIER; HERPES SIMPLEX VACCINE; IMMUNOLOGICAL ADJUVANT; OLIGONUCLEOTIDE; VACCINE; VIRUS ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; CPG ISLAND; DRUG DELIVERY SYSTEM; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNIZATION; IMMUNOLOGY; LIPID BILAYER; METABOLISM; MOUSE; MUCOSA; PATHOLOGY; SKIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CHEMISTRY, PHARMACEUTICAL; CPG ISLANDS; CYTOKINES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; IMMUNIZATION; LIPID BILAYERS; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; OLIGONUCLEOTIDES; SKIN; VACCINES;

EID: 11844299863     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567201043479993     Document Type: Article

References (0)